BBLG vs RGNT: stock comparison and AI forecast
Bone Biologics Corp (BBLG) and Regentis Biomaterials Ltd. (RGNT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BBLG Bone Biologics Corp
- Market Cap
- $1M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
RGNT Regentis Biomaterials Ltd.
- Market Cap
- $8M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- RGNT is 7.5 times larger than BBLG by market capitalization ($8M against $1M).
- RGNT carries 0.61 times debt per unit of equity, against 0.08 times for BBLG.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BBLG | RGNT |
|---|---|---|
| Market Cap | $1M | $8M |
| P/B Ratio | 0.18x | 1.73x |
| EPS | $-0.80 | – |
| Book Value/Share | $1.75 | $0.68 |
Profitability & Margins
| Metric | BBLG | RGNT |
|---|---|---|
| ROE | -47.8% | – |
| ROA | -44.2% | – |
| ROIC | -50.6% | – |
Financial Health
| Metric | BBLG | RGNT |
|---|---|---|
| Current Ratio | 13.38x | – |
| D/E Ratio | 0.08x | 0.61x |
| Financial Leverage | 1.08x | 1.61x |
| Interest Coverage | -3543.3x | -88.2x |
| Working Capital | $6M | – |
Cash Flow
| Metric | BBLG | RGNT |
|---|---|---|
| Operating Cash Flow | -$3M | – |
Income Statement
| Metric | BBLG | RGNT |
|---|---|---|
| Operating Income | -$3M | – |
| Net Income | -$3M | – |
| R&D Expense | $950K | – |
Dividend & Shareholder Information
| Metric | BBLG | RGNT |
|---|---|---|
| Shares Outstanding | 3M | 7M |
BBLG vs RGNT: stock comparison and AI forecast
Which is bigger, BBLG or RGNT?
RGNT is 7.5 times larger than BBLG by market capitalization ($8M against $1M).
Which one does Intratio's AI model rank higher, BBLG or RGNT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.